Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy
COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, India
Dhivya Kandasamy, Shamee Shastry, Deepika Chenna, Ganesh Mohan
10.1016/j.htct.2021.09.019
Hematol Transfus Cell Ther. 2022;44:17-25
Open access
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
Bruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte
10.1016/j.htct.2021.11.015
Hematol Transfus Cell Ther. 2022;44:26-31
Open access
Regarding management of COVID-19 in acute lymphoblastic leukemia
Mohammad Ammad Ud Din
10.1016/j.htct.2021.08.004
Hematol Transfus Cell Ther. 2022;44:120-1
Open access
Response to queries about “COVID-19 and adult acute lymphoblastic leukemia: Presentation and management”
Ayesha Butt, Natasha Ali
10.1016/j.htct.2021.08.009
Hematol Transfus Cell Ther. 2022;44:122-3
Open access
SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility
Roberto Crocchiolo, Francesco Alfarano, Elisabetta Volpato, Mariateresa Pugliano, Irene Cuppari, Anna Maria Mazza, Laura Bellio, Diana Fanti, Chiara Vismara, Francesco Scaglione, Nicoletta Sacchi, Simona Pollichieni, Lia Mele, Elisa Diral, Giovanni Grillo, Silvano Rossini
10.1016/j.htct.2021.09.017
Hematol Transfus Cell Ther. 2022;44:13-6
Open access
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Layane Marques de Souza, Maria do Rosario Ferraz Roberti
10.1016/j.htct.2021.07.008
Hematol Transfus Cell Ther. 2022;44:1-6
Open access
SARS-COV-2: is it a risk for blood transfusion?
Dante Mário Langhi, Renato Cerqueira de Souza, Melca Barros, Gil Cunha De Santis, Simone Haddad Kashima, Jose Orlando Bordin
10.1016/j.htct.2021.08.001
Hematol Transfus Cell Ther. 2022;44:100-3
Open access
Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients
Vildan Gursoy, Suna Avci
10.1016/j.htct.2021.08.013
Hematol Transfus Cell Ther. 2022;44:7-12
Open access
ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review
Sapha Shibeeb, Aisha Khan
10.1016/j.htct.2021.07.006
Hematol Transfus Cell Ther. 2022;44:70-5
Open access
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
10.1016/j.htct.2021.10.979
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19-20
Open access
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.